IHM
IMMU

Iguana Healthcare Management’s Immunomedics Inc IMMU Stock Holding History

Iguana Healthcare Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-150,000
Closed -$1.32M – 83
2017
Q2 		$1.32M Hold
150,000
– – 0.75% 44
2017
Q1 		$971K Buy
+150,000
New +$760K 0.48% 58
2015
Q3 		– Sell
-75,000
Closed -$305K – 85
2015
Q2 		$305K Buy
+75,000
New +$307K 0.1% 67

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Iguana Healthcare Management's IMMU Position: Q1 2018 in Review

Iguana Healthcare Management reduced its Immunomedics Inc (IMMU) stake by 11% in Q1 2018, selling an estimated $817K and leaving 400,000 shares worth $5.84M. The position accounts for 3.84% of the portfolio, ranked #3.

Iguana Healthcare Management first reported a position in IMMU in Q1 2015 and has held it in 10 quarters since. The position peaked at $7.27M in Q4 2017. 168 funds tracked by Wall St. Rank hold IMMU as of Q1 2018.

  • Iguana Healthcare Management held 400,000 shares of Immunomedics Inc worth $5.84M as of Q1 2018.
  • Iguana Healthcare Management sold 50,000 Immunomedics Inc shares in Q1 2018, an estimated $817K.
  • Immunomedics Inc made up 3.84% of Iguana Healthcare Management's portfolio in Q1 2018, its #3 holding.
  • Iguana Healthcare Management first reported a position in Immunomedics Inc in Q1 2015 and has held it in 10 quarters since.
  • Iguana Healthcare Management's Immunomedics Inc position peaked at $7.27M in Q4 2017.
  • 168 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.